Systematic Financial Management LP cut its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 0.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,374,810 shares of the real estate investment trust's stock after selling 16,294 shares during the quarter. Sabra Healthcare REIT accounts for about 1.2% of Systematic Financial Management LP's portfolio, making the stock its 17th biggest position. Systematic Financial Management LP owned approximately 1.00% of Sabra Healthcare REIT worth $41,488,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. SVB Wealth LLC purchased a new stake in shares of Sabra Healthcare REIT during the 1st quarter valued at $34,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Sabra Healthcare REIT by 61.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust's stock valued at $49,000 after purchasing an additional 1,065 shares during the period. RPG Investment Advisory LLC bought a new stake in Sabra Healthcare REIT during the 1st quarter worth approximately $269,000. EntryPoint Capital LLC bought a new stake in Sabra Healthcare REIT during the first quarter valued at $370,000. Finally, Venture Visionary Partners LLC boosted its position in shares of Sabra Healthcare REIT by 8.7% during the 1st quarter. Venture Visionary Partners LLC now owns 116,821 shares of the real estate investment trust's stock valued at $2,041,000 after acquiring an additional 9,301 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company's stock.
Sabra Healthcare REIT Trading Down 0.3%
Shares of Sabra Healthcare REIT stock traded down $0.06 during midday trading on Tuesday, reaching $19.19. 2,596,504 shares of the company's stock traded hands, compared to its average volume of 2,781,370. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. The company has a market cap of $4.60 billion, a PE ratio of 25.25, a price-to-earnings-growth ratio of 1.53 and a beta of 0.86. The stock has a 50 day moving average of $18.49 and a 200-day moving average of $17.73. Sabra Healthcare REIT, Inc. has a 12 month low of $15.60 and a 12 month high of $20.03.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping the consensus estimate of $0.36 by $0.02. The firm had revenue of $189.15 million during the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company's quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the company posted $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.
Sabra Healthcare REIT Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio (DPR) is currently 157.89%.
Analyst Ratings Changes
A number of research analysts recently commented on SBRA shares. BMO Capital Markets increased their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research note on Monday. JMP Securities boosted their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. Finally, Scotiabank lifted their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research note on Monday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $20.29.
Check Out Our Latest Stock Analysis on SBRA
Sabra Healthcare REIT Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Read More

Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.